Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cencora ( (COR) ) just unveiled an announcement.
Cencora, Inc. announced the appointment of Lori J. Ryerkerk to its Board of Directors, effective June 1, 2025. Ms. Ryerkerk, with her extensive experience in global supply chains and leadership roles, is expected to enhance the board’s expertise and support the company’s long-term growth strategy as a healthcare services provider. Additionally, Ornella Barra resigned from the board on May 27, 2025, following Walgreens Boots Alliance’s anticipated ownership reduction in Cencora. This resignation is not due to any disagreements with the company, and WBA does not intend to fill the vacancy.
The most recent analyst rating on (COR) stock is a Hold with a $245.00 price target. To see the full list of analyst forecasts on Cencora stock, see the COR Stock Forecast page.
Spark’s Take on COR Stock
According to Spark, TipRanks’ AI Analyst, COR is a Outperform.
Cencora is performing strongly with robust revenue growth, operational efficiency, and effective cost management. The high leverage is a notable risk, but the company’s strategic focus on expanding its specialty medication offerings and raising guidance reflects confidence in future performance. The technical analysis and valuation suggest caution, as the stock may be experiencing consolidation, and the high P/E ratio points to potential overvaluation.
To see Spark’s full report on COR stock, click here.
More about Cencora
Cencora is a leading global pharmaceutical solutions organization focused on improving the lives of people and animals worldwide. The company collaborates with pharmaceutical innovators to optimize market access to therapies and provides secure, reliable delivery of pharmaceuticals and healthcare products. With over 51,000 employees, Cencora is committed to creating healthier futures and is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500, with more than $290 billion in annual revenue.
Average Trading Volume: 1,873,661
Technical Sentiment Signal: Buy
Current Market Cap: $56.87B
Learn more about COR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue